ConductScience.org, home

Library / Trial comparisons

Patients With Chronic HF Without SDB and NYHA>III vs Patients With Chronic Heart Failure and SDB and NYHA >III: NYHA Class >= III as Predictor for SDB in Chronic HF

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.6960.6810.711wilsonClinicalTrials.gov
Risk in group 20.7340.7180.749wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.0377-0.059-0.0163newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.9490.9210.977logClinicalTrials.gov
Odds ratio, group 1 over group 20.8310.7480.923logClinicalTrials.gov
Number needed to treat, for one fewer participant with the outcome on Patients With Chronic HF Without SDB and NYHA>III than on Patients With Chronic Heart Failure and SDB and NYHA >III26.51761.3from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Patients With Chronic HF Without SDB and NYHA>IIIpatients with chronic heart failure and no sleep disordered breathing who are classified as NYHA \>=III2,5663,686OG000ClinicalTrials.gov
Group 2Patients With Chronic Heart Failure and SDB and NYHA >IIIpatients with chronic heart failure and sleep disorderd breathing who are classified as NYHA \>=III2,3413,190OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleNYHA Class >= III as Predictor for SDB in Chronic HFClinicalTrials.gov
Description
From the total number of participants, the number of male patients without and with SDB were counted and an odds ratio calculated for NYHA (New York Heart Association - class I not impaired, class II slighly impaired, class III severly impaired, class IV = unable to perform normal tasks) class≥III as predictor for SDB in chronic heart failure
ClinicalTrials.gov
Time frame1-time: At baseline physical status was assessed 1 time (anamnesis and medical records)ClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleSleep-Disordered Breathing in Heart Failure - The SchlaHF-RegistryClinicalTrials.gov
NCT numberNCT01500759ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsCongestive Heart Failure, Left Ventricular Systolic DysfunctionClinicalTrials.gov
InterventionsClinicalTrials.gov
Lead sponsorResMedClinicalTrials.gov
Results first posted2020-07-09ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01500759?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.